- Previous Close
126.10 - Open
126.89 - Bid 122.00 x --
- Ask 122.23 x --
- Day's Range
119.61 - 128.00 - 52 Week Range
92.15 - 185.50 - Volume
197,876 - Avg. Volume
680,547 - Market Cap (intraday)
12.867B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
21.69 - EPS (TTM)
5.63 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield 0.50 (0.42%)
- Ex-Dividend Date Jul 19, 2024
- 1y Target Est
--
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
www.blissgvs.com831
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BLISSGVS.NS
View MorePerformance Overview: BLISSGVS.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLISSGVS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLISSGVS.NS
View MoreValuation Measures
Market Cap
12.64B
Enterprise Value
11.26B
Trailing P/E
21.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.58
Price/Book (mrq)
1.25
Enterprise Value/Revenue
1.40
Enterprise Value/EBITDA
8.44
Financial Highlights
Profitability and Income Statement
Profit Margin
7.36%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
8.1B
Net Income Avi to Common (ttm)
596.12M
Diluted EPS (ttm)
5.63
Balance Sheet and Cash Flow
Total Cash (mrq)
2.2B
Total Debt/Equity (mrq)
8.99%
Levered Free Cash Flow (ttm)
--